162 related articles for article (PubMed ID: 36135645)
1. Sensitivity of Serum Beta-D-Glucan in Candidemia According to
Mikulska M; Magnasco L; Signori A; Sepulcri C; Dettori S; Tutino S; Vena A; Miletich F; Ullah N; Morici P; Ball L; Pelosi P; Marchese A; Giacobbe DR; Bassetti M
J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135645
[TBL] [Abstract][Full Text] [Related]
2. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.
Mikulska M; Ullah N; Magnasco L; Codda G; Bartalucci C; Miletich F; Sepulcri C; Willison E; Vena A; Giacobbe DR; di Pilato V; Robba C; Ball L; Marchese A; Bassetti M
Clin Microbiol Infect; 2024 Jun; 30(6):822-827. PubMed ID: 38431255
[TBL] [Abstract][Full Text] [Related]
3. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
[TBL] [Abstract][Full Text] [Related]
4. Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa.
Chibabhai V; Fadana V; Bosman N; Nana T
Mycoses; 2019 Nov; 62(11):1023-1028. PubMed ID: 31393662
[TBL] [Abstract][Full Text] [Related]
5. Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study.
Farooqi J; Niamatullah H; Irfan S; Zafar A; Malik F; Jabeen K
Clin Microbiol Infect; 2021 Oct; 27(10):1519.e1-1519.e5. PubMed ID: 34111581
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia.
Kazancioglu S; Bastug A; Kayaaslan B; Mutlu NM; Calci E; Turhan T; Mumcuoglu I; Akinci E; Bodur H
J Infect Dev Ctries; 2022 Feb; 16(2):362-368. PubMed ID: 35298433
[TBL] [Abstract][Full Text] [Related]
7. Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis.
Mikulska M; Giacobbe DR; Furfaro E; Mesini A; Marchese A; Del Bono V; Viscoli C
Clin Microbiol Infect; 2016 Jul; 22(7):646.e5-8. PubMed ID: 27256062
[TBL] [Abstract][Full Text] [Related]
8. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
Forster J; Dichtl K; Wagener J
Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
10. Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.
Abe M; Kimura M; Araoka H; Taniguchi S; Yoneyama A
Med Mycol; 2014 Nov; 52(8):835-40. PubMed ID: 25349254
[TBL] [Abstract][Full Text] [Related]
11. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
[TBL] [Abstract][Full Text] [Related]
12. Serological biomarkers of candidemia: a retrospective evaluation of three assays.
Dichtl K; Seybold U; Wagener J
Infection; 2019 Apr; 47(2):217-224. PubMed ID: 30264200
[TBL] [Abstract][Full Text] [Related]
13. Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia.
Koc Ö; Kessler HH; Hoenigl M; Wagener J; Suerbaum S; Schubert S; Dichtl K
J Fungi (Basel); 2022 Sep; 8(9):. PubMed ID: 36135696
[TBL] [Abstract][Full Text] [Related]
14. Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia.
Träger J; Dräger S; Mihai S; Cipa F; Busse Grawitz A; Epting T; Meyer R; Rappold E; Held J
J Clin Microbiol; 2023 Nov; 61(11):e0059823. PubMed ID: 37823667
[TBL] [Abstract][Full Text] [Related]
15. Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.
Giacobbe DR; Mikulska M; Tumbarello M; Furfaro E; Spadaro M; Losito AR; Mesini A; De Pascale G; Marchese A; Bruzzone M; Pelosi P; Mussap M; Molin A; Antonelli M; Posteraro B; Sanguinetti M; Viscoli C; Del Bono V;
Crit Care; 2017 Jul; 21(1):176. PubMed ID: 28693606
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards.
Corcione S; Chasseur L; Lupia T; Shbaklo N; Scabini S; Filippini C; Mornese Pinna S; Morra di Celle S; Cavallo R; De Rosa FG
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140525
[TBL] [Abstract][Full Text] [Related]
17. Clinical Profile of Non-neutropenic Patients with Invasive Candidiasis: A Retrospective Study in a Tertiary Care Center.
Sridharan S; Gopalakrishnan R; Nambi PS; Kumar S; Sethuraman N; Ramasubramanian V
Indian J Crit Care Med; 2021 Mar; 25(3):267-272. PubMed ID: 33790505
[No Abstract] [Full Text] [Related]
18. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
[TBL] [Abstract][Full Text] [Related]
20. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.
Poissy J; Sendid B; Damiens S; Ichi Ishibashi K; François N; Kauv M; Favory R; Mathieu D; Poulain D
Crit Care; 2014 Jun; 18(3):R135. PubMed ID: 24975380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
